SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 83 filers reported holding SEELOS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,995 | -36.7% | 43,451 | +137.7% | 0.00% | – |
| Q1 2023 | $12,637 | -25.7% | 18,283 | -26.7% | 0.00% | – |
| Q2 2022 | $17,000 | -39.3% | 24,951 | -25.4% | 0.00% | – |
| Q1 2022 | $28,000 | -81.0% | 33,460 | -63.1% | 0.00% | – |
| Q4 2021 | $147,000 | -68.7% | 90,775 | -53.3% | 0.00% | – |
| Q3 2021 | $469,000 | -18.9% | 194,300 | -11.2% | 0.00% | – |
| Q2 2021 | $578,000 | -76.6% | 218,884 | -55.7% | 0.00% | -100.0% |
| Q1 2021 | $2,466,000 | +10621.7% | 494,135 | +3240.6% | 0.00% | – |
| Q4 2020 | $23,000 | +91.7% | 14,792 | +25.6% | 0.00% | – |
| Q2 2020 | $12,000 | -92.9% | 11,777 | -76.5% | 0.00% | – |
| Q1 2019 | $168,000 | – | 50,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Uniplan Investment Counsel, Inc. | 2,033,020 | $1,904,000 | 0.13% |
| 1492 Capital Management LLC | 150,000 | $141,000 | 0.11% |
| Spark Investment Management LLC | 13,100 | $12,000 | 0.02% |
| ARDSLEY ADVISORY PARTNERS LP | 80,000 | $75,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 27,437 | $26,000 | 0.00% |
| WealthPLAN Partners, LLC | 20,000 | $18,000 | 0.00% |
| CIBC WORLD MARKET INC. | 500,000 | $468,000 | 0.00% |
| CAPITAL COUNSEL LLC/NY | 10,000 | $9,000 | 0.00% |
| J.W. COLE ADVISORS, INC. | 10,000 | $9,000 | 0.00% |
| Renaissance Technologies | 591,086 | $554,000 | 0.00% |